Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

The U.S. 6th Circuit Court of Appeals on Wednesday upheld a lower court’s ruling to dismiss a challenge to the Medicare Drug ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Pharmaceutical companies were dealt back-to-back blows over the last 24 hours in their fight against the Biden-era Medicare ...

An appeals panel found that a pharmaceutical company's participation in Medicare's drug price negotiation program is ...

Three federal courts reject legal challenges to Medicare drug price negotiation Judges side with government in cases filed by ...

The drug price negotiation program has withstood another procedural effort in striking down one of the Inflation Reduction Act’s most significant provisions. | A federal court of appeals judge upheld ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Boehringer Ingelheim Pharmaceuticals Inc. failed to prove to an appeals court that a Biden-era drug pricing program aimed at ...

Boehringer Ingelheim Pharmaceuticals Inc. failed to prove to an appeals court that a Biden-era drug pricing program aimed at ...

The One Big Beautiful Bill Act takes a big step in the rare disease space by expanding the contours of the orphan drug ...